Immunovative Therapies, Ltd.
1 Agudat Sport Hapoel Street
14 articles with Immunovative Therapies, Ltd.
What if you could more precisely control CAR-T cells using FDA-approved small molecules to enhance their activity against solid tumors? That’s exactly what Obsidian Therapeutics is aiming to do.
Immunovative Therapies, Ltd. today announced that it will present at Biotech Showcase™ 2019, to be held January 7–9 at the Hilton San Francisco Union Square.
Checkpoint inhibitors are only effective against inflamed tumors, called ‘hot’ tumors. Unfortunately, most tumors are ‘cold’ (not inflamed) and hide from the immune system by appearing to be too similar to normal cells.
Immunovative Therapies, Ltd. Release: CryoVax : Next Generation Immunotherapy For Metastatic Colorectal Cancer Begins USA Phase IIb Clinical Trial
Tauriga Sciences Inc. Receives Positive Update From Immunovative Therapies, Ltd. And Expected Start Date For Pivotal Phase 2/3 Breast Cancer Trial
Immunovative Inc. Discovers Material Information in Connection With Its Lawsuit Against Immunovative Therapies, Ltd.
Immunovative Inc. Responds to Wrongful Termination Notice of License Agreement and Demands Immediate Return of $3.7 Million Due to Multiple Contractual Breaches by Israeli Based Immunovative Therapies, Ltd.
Immunovative Inc. Announces the Appointment of Dr. Zivile Katiliene as Director of Regulatory Affairs and Clinical Operations for Immunovative Therapies, Ltd.
Immunovative Inc. Announces the Appointment of Professor Emmanuel Katsanis, M.D. as Chief Medical Officer, Medical Director and Chairman of the Scientific Advisory Board of Immunovative Therapies, Ltd.
Immunovative Therapies, Ltd. Announces That Dr. Michael Har-Noy Has Been Invited to Speak at the 5th World Cancer Congress in Beijing, China
Novo Energies Corporation Announces New Name Change to Immunovative Therapies, Ltd. and New Trading Symbol